Du är här


PCI Biotech: Disclosure of voting rights in connection with the Annual General Meeting 13 May 2014

Lysaker, 12 May 2014

In connection with the Annual General Meeting of PCI Biotech Holding ASA to be
held 13 May 2014, Erling Øverland, Chairman of the Board of Directors has
received proxy based voting rights for 4,061,673 shares, representing 52.6
percent of the shares and votes in the company. Erling Øverland owns 32,500
shares and will therefore represent a total of 4,094,173 shares, representing
53.0 percent of the total shares in PCI Biotech Holding ASA. The proxies are
valid only for the Annual General Meeting 13 May 2014.

For further information, please contact:

Ronny Skuggedal, CFO
E-mail: rs@pcibiotech.no
Office: +47 67 11 54 00
Mobile: +47 94 00 57 57

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: PCI Biotech Holding via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.